| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.04 |